ClinConnect ClinConnect Logo
Search / Trial NCT04917432

Early and Midterm Outcomes of Intravascular Ultrasound (IVUS) Versus Non-IVUS Guidance in Complex Coronary Chronic Total Occlusion (CTO) Revascularization.

Launched by ASSIUT UNIVERSITY · Jun 7, 2021

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at the use of a special imaging technique called intravascular ultrasound (IVUS) to help doctors perform a challenging heart procedure known as percutaneous coronary intervention (PCI) for patients with chronic total occlusion (CTO) of the coronary arteries. CTO happens when a major artery is completely blocked for more than three months, leading to symptoms like chest pain. The study aims to compare the outcomes of procedures guided by IVUS versus those guided by traditional methods to see if IVUS can improve results, such as reducing symptoms and improving heart function.

To be eligible for this trial, participants must have significant coronary artery blockages that have been identified through imaging tests and are experiencing symptoms despite taking heart medications. However, patients with recent heart attacks, kidney issues, or who are in unstable health are not eligible. Those who participate can expect to receive care for their heart condition while contributing to valuable research that may help improve treatment techniques for others in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - All coronary CTO patients in whom coronary anatomy is defined by coronary CT and/or Coronary angiography provided that:- CTO defined as heavy atherosclerotic occlusion with TIMI (Thrombolysis in Myocardial Infarction) 0 flow other than via collaterals for \>3 months and they are symptomatic despite optimal medical therapy and/or positive high risk stress modality.
  • Exclusion Criteria:
  • Acute coronary syndrome within 3 months.
  • Patients with renal insufficiency (eGFR \< 60 ml/kg/m2, serum creatinine ≥ 2.5 mg/dL, or on regular dialysis).
  • Patients with expected post CTO-PCI procedure SYNTAX \>10.
  • Hemodynamically unstable patients.

About Assiut University

Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials